Bottom line
QAAHBX vs XLV: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
But QAAHBX is far broader, holding 277 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 1.11% — a difference of $103 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +3.9% for QAAHBX.
Updated Nov 19, 2026
QAAHBX vs XLV side by side
| QAAHBX | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | T. Rowe Price | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.08% |
| Annual cost per $10k | $111 | $8 |
| 10-yr cost on $10k (prospectus) | $1,352 | $103 |
| Max front load | None | None |
| 12b-1 fee | 0.25% | 0.02% |
| 1-yr return | +17.8% | +14.5% |
| 5-yr return (annualized) | +3.9% | +8.1% |
| 10-yr return (annualized) | +8.7% | +9.8% |
| Best quarter | +23.4% | +14.5% |
| Worst quarter | −15.8% | −12.7% |
| Net assets (fund) | $751.7M | $40.6B |
| Number of holdings | 277 | 65 |
| Portfolio turnover | 65% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of QAAHBX's top 25 holdings also appear in XLV's top 25.
| Holding | QAAHBX | XLV |
|---|---|---|
| Eli Lilly & Co | 14.06% | 16.51% |
| Johnson & Johnson | 6.64% | 10.64% |
| Unitedhealth Group Inc | 5.88% | 6.57% |
| Abbvie Inc | 5.12% | 7.74% |
| Merck & Co. Inc. | 4.00% | 5.52% |
| Gilead Sciences Inc | 2.79% | 2.73% |
| Thermo Fisher Scientific Inc | 2.53% | 3.24% |
| Vertex Pharmaceuticals Inc | 2.26% | 2.19% |
| Bristol-myers Squibb Co | 2.12% | 2.05% |
| Abbott Laboratories | 1.91% | 2.75% |
| Intuitive Surgical Inc | 1.89% | 2.45% |
| Amgen Inc | 1.80% | 3.40% |
| Stryker Corp | 1.78% | 1.89% |
| Elevance Health Inc | 1.54% | 1.46% |
| Danaher Corp | 1.44% | 2.09% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between QAAHBX and XLV?
Which is cheaper, QAAHBX or XLV?
Should I own both QAAHBX and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.